NCT00237263View on ClinicalTrials.gov

An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States

PHASE2CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Parkinson's Disease
Interventions
DRUG

Entacapone

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY